May 16, 2025

FDA Approves PD-1–Targeted Monoclonal Antibody for SCAC

The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.

Conexiant

May 16, 2025

Upadacitinib Maintains UC Remission Through 96 Weeks

A 3-year study found that most patients with moderate to severe ulcerative colitis who responded to initial upadacitinib treatment stayed in remission through 96 weeks, with manageable side effects and consistent results across dosage groups.

Conexiant

May 15, 2025

Assistant Professor Salary Gaps Persist Nationwide

Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.

Conexiant

May 15, 2025

Chikungunya Vaccine Linked to Adverse Events

The FDA and CDC have paused use of the Ixchiq chikungunya vaccine in adults aged 60 and older due to reports of serious postmarketing adverse events.

Conexiant

May 14, 2025

Sevoflurane Sedation Linked to Lower ARDS Survival

A large French clinical trial found that patients with moderate to severe ARDS who received sevoflurane had fewer ventilator-free days and lower 90-day survival than those sedated with propofol.

Conexiant

May 14, 2025

Home Wash Leaves Scrubs Full of Superbugs

Home washing machines often fail to disinfect health care workers' uniforms, leaving antibiotic-resistant bacteria behind.

Conexiant

May 09, 2025

FDA Clears First At-Home HPV Test

"This approval is not just about an innovative new product; it’s about finally giving women an option that makes sense for their lives."

Conexiant

May 09, 2025

Measles Cases Top 1,000 in U.S.

U.S. measles cases surpass 1,000 for the first time since 2019, with Texas at the center of the outbreak.

Reuters

May 09, 2025

BAL Guides Treatment in Pediatric Respiratory Illness

BAL detected pathogens in 61% of cases and led to treatment changes in nearly 9 out of 10 immunocompromised children with acute respiratory illness, according to a new 5-year study.

Conexiant